Auro Laboratories Limited has submitted the clippings of Newspaper Publication of the Unaudited Financial Results of the Quarter and Nine Months ended December 31, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Auro Laboratories Limited has submitted to BSE the newspaper clippings of its unaudited financial results for the quarter and nine months ended December 31, 2025, as required under Regulation 47 of SEBI's Listing Regulations. The results were published on February 7, 2026 in Mumbai Lakshdeep (Marathi) and Active Times (English). The Board of Directors approved these results in their meeting held on February 5, 2026. Key numbers from the published extract show Q3 FY26 total income from operations at around Rs. 157.85 lakhs and net profit after tax of Rs. 30.39 lakhs (vs Rs. 6.64 lakhs in Q3 FY25). EPS for Q3 FY26 stood at Rs. 4.28 versus Rs. 2.08 in the year-ago quarter.
This is a routine regulatory compliance filing confirming that results were published in newspapers as required. No new information for shareholders beyond what was already filed under Regulation 33. Likely no material stock price impact from this filing alone, though the underlying results suggest a significant year-on-year improvement in profitability.